Last Updated : September 3, 2024
Details
FilesGeneric Name:
cariprazine
Project Status:
Active
Therapeutic Area:
Schizophrenia
Manufacturer:
AbbVie Corporation
Call for patient/clinician input open:
Brand Name:
Vraylar
Project Line:
Reimbursement Review
Project Number:
SR0827-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A delay outside our control - Deferral of recommendation by expert committee
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
For the treatment of schizophrenia in adults.
Submission Type:
Resubmission
Fee Schedule:
Schedule A
Indications:
For the treatment of schizophrenia in adults.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of Canada's Drug Agency. Reimbursement criteria from Canada's Drug Agency will be documented in the final recommendation, if applicable.
| Call for patient/clinician input open | 08-Nov-23 |
|---|---|
| Call for patient/clinician input closed | 08-Jan-24 |
| Clarification: - Patient input submission received from Schizophrenia Society of Canada | |
| Submission received | 20-Dec-23 |
| Submission accepted | 11-Jan-24 |
| Review initiated | 12-Jan-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 08-Apr-24 |
| Deadline for sponsors comments | 17-Apr-24 |
| CADTH review report(s) and responses to comments provided to sponsor | 09-May-24 |
| Expert committee meeting (initial) | 22-May-24 |
| Clarification: Recommendation deferred to June 26, 2024 CDEC meeting | |
| Draft recommendation issued to sponsor | 10-Jul-24 |
| Draft recommendation posted for stakeholder feedback | 18-Jul-24 |
| End of feedback period | 01-Aug-24 |
| Final recommendation issued to sponsor and drug plans | 15-Aug-24 |
| Final recommendation posted | 03-Sep-24 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 29-Aug-24 |
| CADTH review report(s) posted | - |
Files
Last Updated : September 3, 2024